Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470151) titled 'Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases' on March 10.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
System Lupus Erythematosus(SLE)
Scleroderma
Myasthenia Gravis (MG)
Intervention:
Biological: EVM18001 Injection
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: March 12, 2026
Target Sample Size: 12
Countries of Recruitment:
C...